HK Stock MarketDetailed Quotes

09926 AKESO

Watchlist
  • 60.000
  • -0.850-1.40%
Market Closed Dec 23 16:08 CST
53.85BMarket Cap-66.82P/E (TTM)

AKESO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-72.13%1.02B
440.35%4.53B
2,153.88%3.68B
271.26%837.66M
26.85%163.14M
--225.63M
--128.6M
----
----
2,408.10%70.88M
Operating income
-72.13%1.02B
440.35%4.53B
2,153.88%3.68B
271.26%837.66M
26.85%163.14M
225.63M
128.6M
2,408.10%70.88M
Cost of sales
-5.69%-81.57M
-41.58%-133.25M
-174.57%-77.18M
-201.09%-94.12M
---28.11M
---31.26M
----
----
----
----
Operating expenses
-5.69%-81.57M
-41.58%-133.25M
-174.57%-77.18M
-201.09%-94.12M
-28.11M
-31.26M
Gross profit
-73.80%943.17M
490.82%4.39B
2,565.92%3.6B
282.54%743.54M
5.00%135.03M
194.37M
128.6M
2,408.10%70.88M
Selling expenses
-16.70%-515.98M
-61.11%-890.38M
-195.76%-442.16M
-208.49%-552.66M
---149.5M
---179.15M
----
----
----
----
Administrative expenses
0.77%-99.65M
-0.55%-200.09M
-8.29%-100.43M
18.28%-199.01M
-27.88%-92.74M
3.76%-243.52M
27.13%-72.52M
-356.56%-253.03M
-631.66%-99.52M
-174.95%-55.42M
Research and development expenses
-3.43%-594.39M
5.22%-1.25B
3.48%-574.67M
-17.82%-1.32B
-5.65%-595.38M
-46.11%-1.12B
-134.11%-563.52M
-149.23%-768.59M
-95.35%-240.71M
-91.43%-308.39M
Revaluation surplus
----
----
----
----
----
----
----
-323.51%-412.42M
---412.42M
---97.38M
-Changes in the fair value of other assets
----
----
----
----
----
----
----
-323.51%-412.42M
---412.42M
---97.38M
Special items of operating profit
39.83%63.67M
60.18%-18.99M
71.53%45.53M
-146.09%-47.7M
-59.09%26.55M
-14.79%103.48M
59.12%64.89M
144.88%121.45M
80.05%40.78M
85.62%49.59M
Operating profit
-108.04%-203.18M
247.18%2.03B
473.93%2.53B
-10.51%-1.38B
-52.76%-676.05M
4.94%-1.25B
37.83%-442.55M
-285.24%-1.31B
-523.52%-711.87M
-124.59%-340.72M
Financing cost
-20.19%-46.16M
-100.94%-86.99M
-142.64%-38.41M
-318.18%-43.29M
-338.02%-15.83M
-29.61%-10.35M
44.15%-3.61M
-39.24%-7.99M
-312.17%-6.47M
-116.78%-5.74M
Earning before tax
-110.02%-249.35M
236.58%1.94B
459.82%2.49B
-13.04%-1.42B
-55.07%-691.88M
4.73%-1.26B
37.89%-446.16M
-281.17%-1.32B
-520.65%-718.34M
-124.45%-346.45M
Tax
----
---174K
----
----
----
----
----
----
----
----
After-tax profit from continuing operations
-110.02%-249.35M
236.57%1.94B
459.82%2.49B
-13.04%-1.42B
-55.07%-691.88M
4.73%-1.26B
37.89%-446.16M
-281.17%-1.32B
-520.65%-718.34M
-124.45%-346.45M
Earning after tax
-110.02%-249.35M
236.57%1.94B
459.82%2.49B
-13.04%-1.42B
-55.07%-691.88M
4.73%-1.26B
37.89%-446.16M
-281.17%-1.32B
-520.65%-718.34M
-124.45%-346.45M
Minority profit
69.70%-10.76M
66.14%-85.95M
42.23%-35.5M
-38.55%-253.82M
-189.05%-61.45M
-27.64%-183.19M
53.32%-21.26M
-1,196.78%-143.53M
-841.42%-45.55M
8.13%-11.07M
Profit attributable to shareholders
-109.45%-238.59M
273.60%2.03B
500.52%2.53B
-8.69%-1.17B
-48.37%-630.43M
8.68%-1.07B
36.84%-424.9M
-250.95%-1.18B
-506.66%-672.79M
-135.68%-335.39M
Basic earnings per share
-109.30%-0.28
270.42%2.42
490.91%3.01
-7.58%-1.42
-48.08%-0.77
20.00%-1.32
53.98%-0.52
39.78%-1.65
99.91%-1.13
-2.74
Diluted earnings per share
-109.30%-0.28
270.42%2.42
490.91%3.01
-7.58%-1.42
-48.08%-0.77
20.00%-1.32
53.98%-0.52
39.78%-1.65
99.91%-1.13
-2.74
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024 (FY)Dec 31, 2023 (Q6)Jun 30, 2023 (FY)Dec 31, 2022 (Q6)Jun 30, 2022 (FY)Dec 31, 2021 (Q6)Jun 30, 2021 (FY)Dec 31, 2020 (Q6)Jun 30, 2020 (FY)Dec 31, 2019
Turnover -72.13%1.02B 440.35%4.53B 2,153.88%3.68B 271.26%837.66M 26.85%163.14M --225.63M --128.6M ---- ---- 2,408.10%70.88M
Operating income -72.13%1.02B 440.35%4.53B 2,153.88%3.68B 271.26%837.66M 26.85%163.14M 225.63M 128.6M 2,408.10%70.88M
Cost of sales -5.69%-81.57M -41.58%-133.25M -174.57%-77.18M -201.09%-94.12M ---28.11M ---31.26M ---- ---- ---- ----
Operating expenses -5.69%-81.57M -41.58%-133.25M -174.57%-77.18M -201.09%-94.12M -28.11M -31.26M
Gross profit -73.80%943.17M 490.82%4.39B 2,565.92%3.6B 282.54%743.54M 5.00%135.03M 194.37M 128.6M 2,408.10%70.88M
Selling expenses -16.70%-515.98M -61.11%-890.38M -195.76%-442.16M -208.49%-552.66M ---149.5M ---179.15M ---- ---- ---- ----
Administrative expenses 0.77%-99.65M -0.55%-200.09M -8.29%-100.43M 18.28%-199.01M -27.88%-92.74M 3.76%-243.52M 27.13%-72.52M -356.56%-253.03M -631.66%-99.52M -174.95%-55.42M
Research and development expenses -3.43%-594.39M 5.22%-1.25B 3.48%-574.67M -17.82%-1.32B -5.65%-595.38M -46.11%-1.12B -134.11%-563.52M -149.23%-768.59M -95.35%-240.71M -91.43%-308.39M
Revaluation surplus ---- ---- ---- ---- ---- ---- ---- -323.51%-412.42M ---412.42M ---97.38M
-Changes in the fair value of other assets ---- ---- ---- ---- ---- ---- ---- -323.51%-412.42M ---412.42M ---97.38M
Special items of operating profit 39.83%63.67M 60.18%-18.99M 71.53%45.53M -146.09%-47.7M -59.09%26.55M -14.79%103.48M 59.12%64.89M 144.88%121.45M 80.05%40.78M 85.62%49.59M
Operating profit -108.04%-203.18M 247.18%2.03B 473.93%2.53B -10.51%-1.38B -52.76%-676.05M 4.94%-1.25B 37.83%-442.55M -285.24%-1.31B -523.52%-711.87M -124.59%-340.72M
Financing cost -20.19%-46.16M -100.94%-86.99M -142.64%-38.41M -318.18%-43.29M -338.02%-15.83M -29.61%-10.35M 44.15%-3.61M -39.24%-7.99M -312.17%-6.47M -116.78%-5.74M
Earning before tax -110.02%-249.35M 236.58%1.94B 459.82%2.49B -13.04%-1.42B -55.07%-691.88M 4.73%-1.26B 37.89%-446.16M -281.17%-1.32B -520.65%-718.34M -124.45%-346.45M
Tax ---- ---174K ---- ---- ---- ---- ---- ---- ---- ----
After-tax profit from continuing operations -110.02%-249.35M 236.57%1.94B 459.82%2.49B -13.04%-1.42B -55.07%-691.88M 4.73%-1.26B 37.89%-446.16M -281.17%-1.32B -520.65%-718.34M -124.45%-346.45M
Earning after tax -110.02%-249.35M 236.57%1.94B 459.82%2.49B -13.04%-1.42B -55.07%-691.88M 4.73%-1.26B 37.89%-446.16M -281.17%-1.32B -520.65%-718.34M -124.45%-346.45M
Minority profit 69.70%-10.76M 66.14%-85.95M 42.23%-35.5M -38.55%-253.82M -189.05%-61.45M -27.64%-183.19M 53.32%-21.26M -1,196.78%-143.53M -841.42%-45.55M 8.13%-11.07M
Profit attributable to shareholders -109.45%-238.59M 273.60%2.03B 500.52%2.53B -8.69%-1.17B -48.37%-630.43M 8.68%-1.07B 36.84%-424.9M -250.95%-1.18B -506.66%-672.79M -135.68%-335.39M
Basic earnings per share -109.30%-0.28 270.42%2.42 490.91%3.01 -7.58%-1.42 -48.08%-0.77 20.00%-1.32 53.98%-0.52 39.78%-1.65 99.91%-1.13 -2.74
Diluted earnings per share -109.30%-0.28 270.42%2.42 490.91%3.01 -7.58%-1.42 -48.08%-0.77 20.00%-1.32 53.98%-0.52 39.78%-1.65 99.91%-1.13 -2.74
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards IAS IAS IAS IAS IAS IAS IAS IAS IAS IAS
Audit Opinions -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion
Auditor -- Ernst & Young -- Ernst & Young -- Ernst & Young -- Ernst & Young -- Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biotechnology
Biotechnology
Intraday+0.46%